| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |